About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
1,000
JPY
-18
(-1.77%)
Apr 9, 3:30 pm JST
6.87
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
980
Apr 9, 10:07 pm JST
Summary Chart Historical News Financial Result
PER
276.2
PBR
7.22
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 9, 2025
Opening Apr 9, 9:00 am
1,000 JPY 6.85 USD
Previous Close Apr 8
1,018 JPY 6.90 USD
High Apr 9, 9:01 am
1,060 JPY 7.26 USD
Low Apr 9, 1:43 pm
948 JPY 6.54 USD
Volume
740,500
Trading Value
0.74B JPY 5.07M USD
VWAP
994.7 JPY 6.84 USD
Minimum Trading Value
100,000 JPY 687 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
2,788
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
High
1-Year Average
1,767
1-Year High Jan 27, 2025
28,112
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 0 877,900
Mar 28, 2025 100 1,033,100 10331.00
Mar 21, 2025 8,400 978,800 116.52
Mar 14, 2025 0 710,800
Mar 7, 2025 0 725,500
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.